Corporate Banner
Satellite Banner
Cell Culture
Scientific Community
 
Become a Member | Sign in
Home>News>This Article
  News
Return

Rentschler Announces 3rd Industrial Cell Culture Technology Conference

Published: Saturday, March 15, 2014
Last Updated: Friday, March 14, 2014
Bookmark and Share
“Laupheimer Zelltage” to be held on June 2-3, 2014 in Laupheim, Germany.

Virus-based biologics play an increasing role in the development of innovative gene, immuno and virotherapeutics. Novel virus-based carrier technologies such as virus-like particles are breaking into new vaccine sectors.

The first approval of a gene therapeutic (Glybera®) in Europe as well as various reports of success from gene therapy trials are bolstering confidence in the potential of gene therapy. Also the development of oncolytic viruses for cancer immunotherapy is attracting more and more attention.

Common to all of these virus-based biologics is their high degree of complexity, creating the necessity for high levels of understanding of virus and cell biology as well as a multiplicity of innovative technologies. The manufacturing of virus-based biologics is setting new standards for process development and analytical and regulatory requirements.

Against this background Rentschler invites under the heading Processes for Virus-based Biologics to the third Industrial Cell Culture Technology Conference. The conference will take place on June 2-3, 2014 at Laupheim's historical castle, Schloss Großlaupheim.

With the Industrial Cell Culture Technology Conference “Laupheimer Zelltage” Rentschler has established a unique platform for the international exchange of knowledge, ideas and expertise.

Held every two years, it attracts global leaders and forward thinkers in the field of biotechnology. As these experts discuss the application of cutting-edge developments, important breakthroughs emerge in the manufacturing of biologics.

Processes for Virus-based Biologics include all aspects related to platform technologies for the manufacturing and control of viral biopharmaceuticals including viral vectors, oncolytic viruses and virus-based vaccines.

The conference will bring together international academic and industrial experts in cell culture and process technology for the production of virus-based biologics and is the first conference of its type eagerly awaited by the scientific and industrial community.

The keynote lecture will be held by Florian Wurm (Swiss Federal Institute of Technology). The full program and organization details can be found here: http://rentschler.de/en/information/laupheimer-zelltage/.


Further Information

Join For Free

Access to this exclusive content is for Technology Networks Premium members only.

Join Technology Networks Premium for free access to:

  • Exclusive articles
  • Presentations from international conferences
  • Over 3,000+ scientific posters on ePosters
  • More than 4,400+ scientific videos on LabTube
  • 35 community eNewsletters


Sign In



Forgotten your details? Click Here
If you are not a member you can join here

*Please note: By logging into TechnologyNetworks.com you agree to accept the use of cookies. To find out more about the cookies we use and how to delete them, see our privacy policy.

Related Content

Rentschler Invests EUR 24 Million in Stainless Steel Bioreactor Manufacturing
The Twin system should be operational in early 2017.
Saturday, June 21, 2014
Scientific News
Shape Of Tumor May Affect Whether Cells Can Metastasize
Illinois researchers found that the shape of a tumor may play a role in how cancer cells become primed to spread.
‘Mini-Brains’ to Study Zika
Novel tool expected to speed research on brain and drug development.
Cytokine Triggers Immune Response at Expense of Blood Renewal
Research highlights promise of Anti-IL-1 drugs to treat chronic inflammatory disease.
Micro Heart Muscle Created from Stem Cells
Researchers have designed a new way to create micro heart muscle from stem cells using a unique dog bone dish.
“Secret Sauce” for Personalized, Functional Insulin-producing Cells
Researchers uncover molecular switch to make effective sugar-responsive, insulin-releasing cells in a dish, offering hope for diabetes therapy.
Insights into Early Human Embryo Development
Researchers at Karolinska Institutet and the Ludwig Cancer Research in Stockholm have conducted a detailed molecular analysis of the embryo’s first week of development.
Boosting Gene Transfer Capabilities
A new and highly efficient method for gene transfer has been developed.
Liver-On-Chip Tracks Dynamics of Cellular Function
Hebrew University’s liver-on-chip platform is uniquely able to monitor metabolic changes indicating mitochondrial damage occurring at drug concentrations previously regarded as safe.
EU Project Aims to Cure Type 1 Diabetes
Researchers develop organoids from insulin-producing cells for transplantation.
Hope for Combating Muscular Dystrophy
Decoding a sugar molecule and identifying a mechanism linking it to MS could help in the development of therapy for the disease.
SELECTBIO

SELECTBIO Market Reports
Go to LabTube
Go to eposters
 
Access to the latest scientific news
Exclusive articles
Upload and share your posters on ePosters
Latest presentations and webinars
View a library of 1,800+ scientific and medical posters
3,000+ scientific and medical posters
A library of 2,500+ scientific videos on LabTube
4,400+ scientific videos
Close
Premium CrownJOIN TECHNOLOGY NETWORKS PREMIUM FOR FREE!